Paige is advancing cancer diagnostics through the integration of artificial intelligence in the pathology field. Their AI applications assist pathologists in various stages of diagnosis, providing enhanced insights to improve patient care. Utilizing one of the most extensive and diverse datasets in pathology, Paige became the first to receive FDA approval for an AI product in this field. Their web-based platform combines advanced digital pathology tools and third-party AI solutions, addressing the major challenges faced by labs to enable more efficient and accurate diagnoses. Headquartered in New York and operating globally, Paige aims to transform cancer care while upholding high standards of security and compliance. Their commitment to innovation is underpinned by a collaborative work environment that values diversity and inclusion.